Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.

33 recruiting in this ClinicalTrials.gov snapshot · reviewed 2026-08-17

Endometriosis clinical trials, in English

Endometriosis trials may require surgical diagnosis or imaging plus symptoms. Pain scores, hormone therapy washouts, and pregnancy plans are common filters. This hub does not advise on surgery or fertility. Sourced from ClinicalTrials.gov. Not a recommendation to join any study.

How to read this list

Each headline is a rewrite of registry fields (phase, intervention, condition). Open the NCT link before you call a site. Eligibility is decided by the study team, not by this page. See how to find a trial and eligibility explained.

Phases in this snapshot: Not a traditional drug phase (28) · Phase 4 (2) · Phase 3 (1) · Phase 2 (1) · Phase 1 (1)

Cities that appear on these records

  • Barcelona, Spain · 3
  • Madrid, Spain · 3
  • Montreal, Quebec · 2
  • Poznan, Poland · 2
  • L'Hospitalet de Llobregat, Barcelona · 2
  • Bordeaux, France · 2
  • Rennes, France · 2
  • Leuven, Belgium · 2

Browse by US state · city hubs

Intervention hubs that overlap this snapshot: Pembrolizumab

RecruitingNot a traditional drug phaseScottsdale, Arizona
Not a traditional drug phase: Quality-of-Life Assessment for Cervical Carcinoma

This early phase I trial compares the side effects between patients treated with proton radiation therapy versus intensity modulated radiation therapy after surgery for the treatment of endometrial or cervical cancer. Radiation therapy uses high energy protons or x-rays to kill tumor cells and shrink tumors.

NCT04567771 · Official ClinicalTrials.gov record · Mayo Clinic

RecruitingNot a traditional drug phaseChandler, Arizona
Not a traditional drug phase: Observational study, no intervention for Endometriosis

The goal of this watch-and-measure (no experimental treatment required) study is to determine the clinical validity of a deep neural network algorithm that utilizes protein biomarker detection of Endometriosis - "EndoCheck" - as an "aid in diagnosis" for endometriosis and to show validity as a diagnostic test

NCT05245695 · Official ClinicalTrials.gov record · Aspira Women's Health

RecruitingNot a traditional drug phaseMontreal, Quebec
Not a traditional drug phase: Implementation of elleFA smartphone application for Endometriosis

Endometriosis is a chronic incurable disease where endometrial-like tissue grows outside of the uterus, and causes symptoms such as debilitating menstrual pain, pain during intercourse, infertility, constipation, and bloating, which hurts their quality of life. Endometriosis is estimated to affect approximately 10% of women.

NCT06452407 · Official ClinicalTrials.gov record · McGill University Health Centre/Research Institute of the McGill University Health Centre

RecruitingNot a traditional drug phaseMilan
Not a traditional drug phase: anti-inflammatory diet for Endometriosis

The goal of this randomly assigned controlled trial is to assess whether a 12-week anti-inflammatory diet can improve fertility outcomes in women with endometriosis undergoing In Vitro Fertilization (IVF). The main questions are: * Does the anti-inflammatory diet reduce the rate of inadequate ovarian response to hormonal stimulation (retrieval of ≤3 oocytes)?

NCT06885125 · Official ClinicalTrials.gov record · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

RecruitingNot a traditional drug phasePalma de Mallorca, Balearic Islands
Not a traditional drug phase: Ultrasound-guided aspiration and alcohol sclerotherapy for Endometrioma

The goal of this clinical trial is to evaluate whether ultrasound-guided alcohol sclerotherapy can improve pelvic pain and quality of life in women aged 18 to 45 diagnosed with ovarian endometriomas, compared to expectant management. The main questions it aims to answer are: 1.

NCT06955221 · Official ClinicalTrials.gov record · Hospital Universitari de Bellvitge

RecruitingNot a traditional drug phaseTübingen, Germany
Not a traditional drug phase: APC for Endometriosis

The study is a prospective, monocentric, randomly assigned controlled, two-armed, pilot-study conducted at Department for Women's Health, Tuebingen, Germany. In this Post Market Study it will be determined whether and to what extent the two surgical procedures for ovarian endometrioma treatment (standard cystectomy versus APC) may affect the ovarian reserve by comparing changes in serum AMH levels after treatment.

NCT07065214 · Official ClinicalTrials.gov record · Erbe Elektromedizin GmbH

RecruitingNot a traditional drug phaseLeuven
Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms

The goal of this study/research is to assess the relationship between ultrasound features of the myometrium suggestive of adenomyosis and clinical symptoms of adenomyosis and to establish a reporting system for adenomyosis assessing disease severity. Consecutive pre- and perimenopausal symptomatic and asymptomicasymptomatic women with an uterus presenting for gynaecological ultrasound exams will be asked to participate in the study.

NCT07397715 · Official ClinicalTrials.gov record · Swiss GO Trial Group

RecruitingNot a traditional drug phaseChicago, Illinois
Outpatient Visits Versus Telehealth for Postoperative Care After Minimally Invasive Gynecologic Surgery

Telehealth, or telemedicine, utilizes technology to deliver clinical care remotely, either in real time or asynchronously, between clinician and patient. Telemedicine has been successfully implemented to increase healthcare delivery for patients in rural areas with otherwise long travel times, and studies have also determined that telemedicine can increase patient satisfaction scores while simultaneously decreasing direct and indirect costs for patients.

NCT07420114 · Official ClinicalTrials.gov record · University of Chicago

RecruitingPhase 2Boston, Massachusetts
Phase 2: testing Sacituzumab tirumotecan for Ovarian Clear Cell Carcinoma

This is a phase II, two-arm, noncomparative screening study of Sacituzumab tirumotecan, an intravenous antibody-drug conjugate (ADC) that targets Trop-1, administered alone or in combination with pembrolizumab, a monoclonal antibody to PD-1 in patients with relapsed clear cell cancers that originated in the ovary, fallopian tube or peritoneal cavity, inclusive of endometriosis (collectively referred to as OCCC throughout the protocol) after previous treatment with anti-PD1 therapy. The regimens will be evaluated separately, and the study is not designed or powered to compare the regimens.

NCT07718854 · Official ClinicalTrials.gov record · Tufts Medical Center

RecruitingPhase 1Changsha, Hunan
Phase 1: testing HHK001 for Endometriosis

The goal of this clinical trial is to find out how the study drug HHK001 compares to Enantone (an approved treatment for endometriosis) when given as a single 3.75 mg injection to participants with endometriosis. Both products contain the same active ingredient: leuprorelin acetate.

NCT07755956 · Official ClinicalTrials.gov record · Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.

RecruitingNot a traditional drug phasePrague
Deep Endometriosis Affecting the Urogenital Tract: Long-term Outcomes and Impact on Renal Function

Endometriosis is a chronic estrogen-dependent disease characterized by the presence and growth of endometrium-like tissue outside the uterine cavity. This ectopic endometrial tissue induces a chronic local and systemic inflammatory response, resulting in the most common manifestations of the disease: chronic pelvic pain, infertility, and pelvic adhesions.

NCT07776574 · Official ClinicalTrials.gov record · Charles University, Czech Republic

RecruitingNot a traditional drug phaseNew York, New York
Not a traditional drug phase: Reinforcement Learning (RL)-Based Personalized Exercise Recommendations for Pelvic Pain

WorkoutCPP is a pilot study evaluating the feasibility of a personalized exercise recommendation system for individuals with chronic pelvic pain disorders (CPPDs). The study uses reinforcement learning (RL), a type of artificial intelligence that adapts recommendations over time based on each participant's reported pain levels, symptom burden, and exercise compliance.

NCT07810218 · Official ClinicalTrials.gov record · Icahn School of Medicine at Mount Sinai

RecruitingNot a traditional drug phaseBudapest, Budapest
Artificial Intelligence Into Ultrasound Diagnostics in Reproductive Medicine

The goal of this watch-and-measure (no experimental treatment required) study is to develop and validate artificial intelligence (AI)-based algorithms that support ultrasound diagnosis of endometriosis, adenomyosis, myometrial masses, uterine malformations, and impaired endometrial receptivity in women aged 18-45 years. The main questions it aims to answer are: Can AI algorithms, applied to standardized transvaginal ultrasound images, accurately detect and classify endometriosis and adenomyosis in real time during routine examination?

NCT07810920 · Official ClinicalTrials.gov record · Semmelweis University

RecruitingNot a traditional drug phasePeschiera del Garda, Verona
Not a traditional drug phase: Retrospective case-control analysis for Endometriosis

This study hypothesizes that the histological, immunophenotypic, and molecular characterization of atypical endometriotic lesions may be related to specific clinical and ultrasound features.Identifying potentially atypical lesions would allow for more accurate stratification of patients, distinguishing definitely benign from potentially atypical endometriosis. The targeted study of endometriosis, both typical and atypical, also with reference to the inflammatory microenvironment, as well as immunophenotypic and molecular characteristics, could allow the formulation of pathogenic hypotheses on the development and progression of atypia towards malignant neoplasms.

NCT07816133 · Official ClinicalTrials.gov record · Casa di Cura Dott. Pederzoli

RecruitingNot a traditional drug phaseHuai'an, Jiangsu
Not a traditional drug phase: testing DEX 0.2 μg/kg/h. for Uterine Fibroids (Leiomyoma)

Study Objectives This study aims to investigate the effects of preoperative stellate ganglion block and intraoperative intravenous dexmedetomidine on postoperative sleep disturbance in patients undergoing laparoscopic gynecologic surgery, with the goals of reducing pain and postoperative adverse reactions and identifying an effective, safe, economical, and broadly applicable intervention strategy that may facilitate emergence from anesthesia, accelerate postoperative recovery, shorten the length of hospital stay, and reduce hospitalization costs. This trial aims to determine whether preoperative stellate ganglion block (SGB) and intraoperative intravenous dexmedetomidine (DEX) can improve postoperative sleep quality in patients undergoing laparoscopic gynecologic surgery, and whether the combination of these two interventions provides an interaction effect or additional ben

NCT07860203 · Official ClinicalTrials.gov record · Catherin Zhang

RecruitingNot a traditional drug phaseStrasbourg
3D Modeling of Deep Endometriosis From Pelvic MRI

This retrospective monocentric study aims to assess the feasibility and clinical relevance of three-dimensional (3D) modeling of deep endometriosis lesions derived from pelvic MRI. The study evaluates whether 3D reconstruction improves surgical planning and multidisciplinary management.

NCT07864883 · Official ClinicalTrials.gov record · University Hospital, Strasbourg, France

RecruitingNot a traditional drug phaseSan Francisco, California
Not a traditional drug phase: Fiber for Endometriosis

This study is a neither you nor the study doctors know who gets the real treatment, randomly assigned, compared with a dummy treatment study that evaluates the whether it is safe and how hard side effects are to live with of a fiber-based dietary supplement and the mechanistic and structure-function effects of that supplement on the gut and vaginal microbiome, gastrointestinal well-being, and quality-of-life parameters in 140 women with endometriosis and co-existing gastrointestinal symptoms over 12 weeks. The primary objective is to measure the whether it is safe and how hard side effects are to live with of the supplement, measured by the incidence and severity of gastrointestinal side effects (AEs) and discontinuations.

NCT07875062 · Official ClinicalTrials.gov record · LOAM Science

RecruitingNot a traditional drug phaseLeuven
Not a traditional drug phase: [18F]AlF-FAPI-74 PET/CT for Endometriosis

The goal of this clinical trial is to learn whether \[18F\]AlF-FAPI-74 PET/CT can help detect endometriosis in adult women who are already scheduled for laparoscopy due to suspicion of deep infiltrating endometriosis or superficial peritoneal endometriosis. The main aims are: (i) How well does \[18F\]AlF-FAPI-74 PET/CT identify endometriosis lesions compared with findings during laparoscopy?

NCT07876648 · Official ClinicalTrials.gov record · Universitaire Ziekenhuizen KU Leuven

RecruitingNot a traditional drug phaseAmiens
Not a traditional drug phase: Perioperative quantitative sensory testing for Endometriosis

The pain associated with endometriosis reflects a multifactorial pathophysiology combining peripheral nociception, central sensitisation and psychosocial factors. Although surgery is an integral part of treatment, a significant proportion of patients experience persistent pain several months after the procedure.

NCT07882498 · Official ClinicalTrials.gov record · Centre Hospitalier Universitaire, Amiens

FAQ: Endometriosis trials

How do I find recruiting Endometriosis clinical trials?

This hub lists 33 recruiting Endometriosis studies from a ClinicalTrials.gov snapshot, rewritten in plain English. Each card links to its NCT record. You can also search the official registry for “endometriosis” at https://clinicaltrials.gov/search?cond=endometriosis.

What does a Endometriosis trial page on PlainTrials include?

A phase explainer, a plain-English summary grounded in the brief summary, inclusion/exclusion extracted from the public eligibility block, sponsor name, and any central contact the sponsor published. It is not a match to a trial.

Where are Endometriosis studies located in this snapshot?

Sites that appear on these records include Barcelona, Spain; Madrid, Spain; Montreal, Quebec; Poznan, Poland; L'Hospitalet de Llobregat, Barcelona. A city on a record is not a guarantee that the site is taking new patients this week — call the NCT contact.

Can PlainTrials tell me if I qualify for a Endometriosis study?

No. Eligibility is decided by the study team using the protocol, labs, and consent. Our “who it is for” list is a readable extract of public inclusion text only.